28

2024

-

09

Wuhan University Shu Hongbing Team to Take Progress Again

Author:


 

Dysregulation of protein homeostasis results in the accumulation of protein aggregates sequestered in dedicated insoluble chambers, called inclusion bodies or aggregates, where they are cleared by different mechanisms to reduce protein toxicity. These protein aggregates can be selectively cleared by macrophage/autophagy, which is called aggregate autophagy (aggrephagy) and is mediated by the autophagy receptor SQSTM1.

On June 19, 2024, Shu Hongbing and Li Shu of Wuhan University jointly communicatedAutophagy onlinePublished entitled"PLK2-mediated phosphorylation of SQSTM1 S349 promote aggregation of polyubiquitinated proteins on proteasomal dysfunctionThe study found thatPLK2 is an important regulator of SQSTM1-mediated aggregation of polyubiquitinated proteins.

PLK2 is upregulated upon proteasome inhibition and then binds to and phosphorylates SQSTM1 at the S349 site. Phosphorylation of SQSTM1 S349 enhances its binding to KEAP1, which is required for the formation of large SQSTM1 aggregates/bodies upon proteasome inhibition.Taken together, our results suggest that PLK2-mediated SQSTM1 S349 phosphorylation is a key regulatory mechanism for SQSTM1-mediated aggregation of polyubiquitinated proteins.

In addition, on September 23, 2024, the Shu Hongbing team of Wuhan University was inThe Journal of ImmunologyPublished online entitled“MARCH8 mediaates k27-linked polyubiquitination of IL-7 receptor α to negative regulated IL-7–Triggered T cell homeostasis”The research paper,The study showedMARCH8-mediated negative regulation of K27-associated IL-7Rα polyubiquitination IL-7 triggers T-cell homeostasis.The study found that the membrane-associated RING-CH (MARCH) E3 ligase family member MARCH8 mediates K27-associated IL-7Rα polyubiquitination, leading to its lysosomal degradation. Site-directed mutagenesis showed that MARCH8 mediates polyubiquitination of IL-7Rα at the K265/K266 site, and mutations of these residues make IL-7Rα resistant to MARCH8-mediated polyubiquitination and degradation. In human T lymphoma cells, increased MARCH8 deficiency IL-7 trigger activation of the downstream transcription factor STAT5 and transcriptional induction of effector genes. In mice, MARCH8 deficiency also promotes IL-7-triggered T cell proliferation and splenic memory CD8+T cell differentiation.The results show that MARCH8 negatively regulates the signaling pathway triggered by IL-7 by mediating K27-related polyubiquitination and lysosomal degradation of IL-7Rα, revealing the negative regulatory mechanism of IL-7 triggering T cell homeostasis (Click to read)。

On April 13, 2024, Wuhan University Shu Hongbing, Yao Jing, Zhong Bo and Lin Dandan cooperated inCell ReportsOnline published the title"Viral infection and spread are inhied by the polyubiquitination and downregulation of TRPV2 channel by the interferon-stimulated gene TRIM21"The research paper,This study reports that one ISG, TRIM21, interacts with and degrades the TRPV2 channel in myeloid cells, reducing its expression and providing host protection against viral infection.In addition, viral infection upregulates TRIM21 and down-regulates TRPV2 in neighboring cells in a paracrine and autocrine manner to prevent virus transmission to uninfected cells. Consistent,Trim21-/-miceTrim21 / cubs are more susceptible to HSV-1 and VSV, whileTrim21 / Pups rescue virus susceptibility by inhibiting or deleting TRPV2. Mechanically, TRIM21 catalyzes the K48-linked ubiquitination of TRPV2 at the Lys295 locus. TRPV2K295Rresistance to virus infection-induced TRIM21-dependent ubiquitination and degradation, when recombinantLyz2-Cre;Trpv2fl/flbone marrow cells, promote viral infection more profoundly than wild-type TRPV2.These findings suggest that targeting the TRIM21-TRPV2 axis is a favorable strategy to control viral spread to bystander cells

 

Protein homeostasis is a critical requirement for cellular metabolism, organelle biogenesis, stress adaptation, and the viability and physiological processes of all cell types, tissues and organs.Protein homeostasis systems include cellular processes in living systems that collectively regulate protein turnover, structure, and function. Proper regulation of protein homeostasis is important to combat the deleterious consequences of unfolded, misfolded, damaged, or excessively accumulated proteins that severely disrupt cellular function and are associated with aging and age-related diseases, including neurodegenerative diseases, cancer, and immune and metabolic diseases. The ubiquitin-proteasome system (UPS) and the autophagy-lysosome pathway are two major pathways that synergistically detect and remove target proteins. However, these protein degradation systems may be dysfunctional under various external and endogenous stress conditions.

When the UPS is damaged or overloaded, the target protein accumulates, forming protein aggregates, which are then sequestered into dedicated insoluble compartments, so-called inclusion bodies or aggregates, where they are cleared by different mechanisms to reduce protein toxicity.Protein aggregates can be selectively cleared by autophagy, termed aggregate autophagy (aggrephagy). In this process, the autophagy receptor SQSTM1/p62 (sequestosome 1) separates the protein aggregates into specialized aggregates called SQSTM1 bodies, which are ultimately directed to lysosomes for proteolytic degradation. SQSTM1 contains multiple domains that are necessary for its role in the aggregation. The N-terminal PB1 domain mediates its homo-oligomerization, increases its affinity for protein aggregates, and promotes the formation of SQSTM1 bodies.The C- terminal ubiquitin-associated domain interacts with polyubiquitinated protein aggregates. The phosphorylation of SQSTM1 S403 in this domain increases its affinity with polyubiquitin chains, thereby effectively isolating polyubiquitinated proteins into SQSTM1 bodies.

SQSTM1 also contains a KEAP1 interaction region, which mediates the phosphorylation of KEAP1 binding SQSTM1 at S349, resulting in the release of the transcription factor NFE2L2/NRF2 by KEAP1, which regulates downstream gene expression.Over the past decade, studies have shown that the disorder of SQSTM1 is associated with neurodegenerative diseases such as Parkinson's disease, Alzheimer's disease, amyotrophic lateral sclerosis, Huntington's disease, and tumorigenesis. Therefore, understanding the regulatory mechanism of SQSTM1 body formation is essential for understanding the maintenance of protein balance and age-related diseases.
Polo-like kinases constitute a family of serine/threonine kinases that play critical regulatory roles in cell cycle progression, cell division, centriole replication, mitosis, and DNA damage responses.Mammals have PLK1, PLK2/SNK, PLK3/FNK, PLK4/SAK and PLK5 five members of the PLK family. All polo-like kinases contain an N-terminal serine/threonine kinase domain and a C- terminal polo- box domain that mediates protein-protein interactions. PLK1, PLK2 and PLK3 showed significant sequence homology in their kinase domains, whereas PLK4 had stronger sequence homology and PLK5 contained only one pseudo-kinase domain. In the past few years, various studies have focused on the non-mitotic functions of PLK2. Studies have shown that PLK2 promotes the degradation of several proteins through phosphorylation, thereby regulating cell function. For example, PLK2 is upregulated following over-activation of hippocampal neurons, leading to degeneration of spinal-related RapGAP and feedback reduction of neuronal excitability.
PLK2 is required for activity-induced APP (β-amyloid precursor protein) depletion, suggesting that PLK2 plays a critical role in maintaining synaptic activity-dependent APP metabolism.PLK2 binds to the E3 ubiquitin ligase FBXW7 and leads to its degradation, promoting the growth of rectal tumors. In Parkinson's disease, SNCA/α-Syn (synu- clein α) determines the progression of the disease. Studies have shown that PLK2 interacts with the N-terminus of SNCA, leading to its degradation through autophagy. Plk2 deficiency decreases phosphorylation and aggregation of SNCA, thereby reducing neuronal mortality. These observations suggest that PLK2 has a preferential role in protein quiescence. However, whether and how PLK2 is involved in protein stasis is unclear.

This study identified SQSTM1 as a PLK2 related protein.Proteasome dysfunction induces rapid upregulation of PLK2, which phosphorylates the S349 site of human SQSTM1 (HsSQSTM1) or the S351 site of mouse SQSTM1 (MmSQSTM1). This phosphorylation process enhances the binding of SQSTM1 to KEAP1, resulting in SQSTM1-mediated aggregation of polyubiquitinated proteins. Upon induction of proteasome dysfunction, PLK2 deficiency inhibits the formation of SQSTM1 bodies containing K48-linked polyubiquitinated proteins. Further experiments showed that PLK2 phosphorylation of SQSTM1 S349 is required for its oligomerization, but does not bind to multimeric deprotins.In conclusion, this study demonstrates that PLK2-mediated phosphorylation of SQSMT1 S349 is a key regulatory mechanism for SQSTM1-mediated aggregation of polyubiquitinated proteins.

Chongqing Chongfan Technology Co., Ltd. Optical platform film thickness meter OCT optical coherence tomography LabVIEW control